These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 26420624

  • 1. Elevated Intact Proinsulin Levels During an Oral Glucose Challenge Indicate Progressive ß-Cell Dysfunction and May Be Predictive for Development of Type 2 Diabetes.
    Pfützner A, Hermanns I, Ramljak S, Demircik F, Pfützner AH, Kann PH, Weber MM.
    J Diabetes Sci Technol; 2015 Sep 29; 9(6):1307-12. PubMed ID: 26420624
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance.
    Davies MJ, Rayman G, Gray IP, Day JL, Hales CN.
    Diabet Med; 1993 May 29; 10(4):313-20. PubMed ID: 8508612
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Increased Intact Proinsulin in the Oral Glucose Challenge Sample is an Early Indicator for Future Type 2 Diabetes Development - Case Reports and Evidence from the Literature.
    Pfützner A, Manessis A, Hanna MR, Lewin J.
    Clin Lab; 2020 May 01; 66(5):. PubMed ID: 32390400
    [Abstract] [Full Text] [Related]

  • 6. Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes.
    Pfützner A, Kunt T, Hohberg C, Mondok A, Pahler S, Konrad T, Lübben G, Forst T.
    Diabetes Care; 2004 Mar 01; 27(3):682-7. PubMed ID: 14988285
    [Abstract] [Full Text] [Related]

  • 7. Specific insulin and proinsulin in normal glucose tolerant first-degree relatives of NIDDM patients.
    Coifman R, Dalbosco IS, Russo EM, Moisés RS.
    Braz J Med Biol Res; 1999 Jan 01; 32(1):67-72. PubMed ID: 10347771
    [Abstract] [Full Text] [Related]

  • 8. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK, Mohamed Ali V, Jain SK, Walji S, Yudkin JS.
    Diabet Med; 1996 Jan 01; 13(1):59-64. PubMed ID: 8741814
    [Abstract] [Full Text] [Related]

  • 9. Are specific serum insulin levels low in impaired glucose tolerance and type II diabetes?: measurement with a radioimmunoassay blind to proinsulin, in the population of Wadena, Minnesota.
    Goetz FC, French LR, Thomas W, Gingerich RL, Clements JP.
    Metabolism; 1995 Oct 01; 44(10):1371-6. PubMed ID: 7476300
    [Abstract] [Full Text] [Related]

  • 10. Increased secretion of 32,33 split proinsulin after intravenous glucose in glucose-tolerant first-degree relatives of patients with non-insulin dependent diabetes of European, but not Asian, origin.
    Gelding SV, Andres C, Niththyananthan R, Gray IP, Mather H, Johnston DG.
    Clin Endocrinol (Oxf); 1995 Mar 01; 42(3):255-64. PubMed ID: 7758230
    [Abstract] [Full Text] [Related]

  • 11. Clinical and Laboratory Evaluation of a New Specific Point-of-Care Test for Intact Proinsulin.
    Pfützner A, Pfützner AH, Kann PH, Burgard G.
    J Diabetes Sci Technol; 2017 Mar 01; 11(2):278-283. PubMed ID: 27559030
    [Abstract] [Full Text] [Related]

  • 12. Intact proinsulin, des 31,32 proinsulin, and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetes.
    Nagi DK, Knowler WC, Mohamed-Ali V, Bennett PH, Yudkin JS.
    Diabetes Care; 1998 Jan 01; 21(1):127-33. PubMed ID: 9538983
    [Abstract] [Full Text] [Related]

  • 13. A higher proinsulin response to glucose loading predicts deteriorating fasting plasma glucose and worsening to diabetes in subjects with impaired glucose tolerance.
    Inoue I, Takahashi K, Katayama S, Harada Y, Negishi K, Ishii J, Shibazaki S, Nagai M, Kawazu S.
    Diabet Med; 1996 Apr 01; 13(4):330-6. PubMed ID: 9162608
    [Abstract] [Full Text] [Related]

  • 14. Excessive secretion of insulin precursors characterizes and predicts gestational diabetes.
    Swinn RA, Wareham NJ, Gregory R, Curling V, Clark PM, Dalton KJ, Edwards OM, O'Rahilly S.
    Diabetes; 1995 Aug 01; 44(8):911-5. PubMed ID: 7621996
    [Abstract] [Full Text] [Related]

  • 15. Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women.
    Pradhan AD, Manson JE, Meigs JB, Rifai N, Buring JE, Liu S, Ridker PM.
    Am J Med; 2003 Apr 15; 114(6):438-44. PubMed ID: 12727576
    [Abstract] [Full Text] [Related]

  • 16. Fasting proinsulin concentrations predict the development of type 2 diabetes.
    Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN.
    Diabetes Care; 1999 Feb 15; 22(2):262-70. PubMed ID: 10333943
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increased molar proinsulin-to-insulin ratio in women with previous gestational diabetes does not predict later impairment of glucose tolerance.
    Hanson U, Persson B, Hartling SG, Binder C.
    Diabetes Care; 1996 Jan 15; 19(1):17-20. PubMed ID: 8720527
    [Abstract] [Full Text] [Related]

  • 19. In type 2 diabetes patients, insulin glargine is associated with lower postprandial release of intact proinsulin compared with sulfonylurea treatment.
    Pscherer S, Larbig M, von Stritsky B, Pfützner A, Forst T.
    J Diabetes Sci Technol; 2012 May 01; 6(3):634-40. PubMed ID: 22768894
    [Abstract] [Full Text] [Related]

  • 20. [Predictors of abnormal glucose tolerance in persons at risk of type 2 diabetes: the RIAD study].
    Henkel E, Köhler C, Temelkova-Kurktschiev T, Hanefeld M.
    Dtsch Med Wochenschr; 2002 May 03; 127(18):953-7. PubMed ID: 11987015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.